MR编号 | FI/H/1194/001 |
---|
药品名称 | Cyclophosphamide Accord |
---|
活性成分 | - Cyclophosphamide 200.0 mg/ml
|
---|
剂型 | Concentrate for solution for injection/infusion |
---|
上市许可持有人 | Accord Healthcare
Winthontlaan 200, 3526 KW Utrecht
Netherlands |
---|
参考成员国 - 产品名称 | Finland (FI) Cyclophosphamide Accord |
---|
互认成员国 - 产品名称 | - Latvia (LV)
- Lithuania (LT)
- Germany (DE)
Cyclophosphamid Accord 200 mg/ml Konzentrat zur Herstellung einer Injektions-/Infusionslösung - Estonia (EE)
- Denmark (DK)
- Bulgaria (BG)
- Belgium (BE)
Cyclofosfamide Accord 200 mg/ml concentraat voor oplossing voor injectie/infusie - Cyprus (CY)
Cyclophosphamide Accord 200 mg/ml concentrate for solution for injection/infusion - France (FR)
- Czechia (CZ)
Cyclophosphamide Accord - Spain (ES)
- Romania (RO)
- Portugal (PT)
- Croatia (HR)
- Italy (IT)
- Sweden (SE)
- Norway (NO)
- Poland (PL)
Cyclophosphamide Accord
|
---|
许可日期 | 2024/03/13 |
---|
最近更新日期 | 2024/11/21 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:Known Active Substance
- TypeLevel2:Initial Application
- TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|